AUC · k for variable inter-occasion CL [NCA / SHAM]

posted by PharmCat  – Russia, 2021-10-01 00:15 (66 d 00:17 ago) – Posting: # 22609
Views: 1,007

Hey!
Helmut,
Sounds great. One problem ... I don't think that our regulators will be able to understand this, or there will be a desire and dare to change the foundations. Also, I think NLME modeling can be applied.

Complete thread:

Activity
 Admin contact
21,785 posts in 4,556 threads, 1,547 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time: Sunday 23:32 CET (Europe/Vienna)

Every man is fully satisfied that there is such a thing as truth,
or he would not ask any question.    Charles Sanders Peirce

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5